EBS MEXC RealStocks
Own real EBS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 14:35:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Emergent Biosolutions, Inc. (EBS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $6.03, with a market capitalization of $311.06M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.36 to $14.06. This page covers its latest market performance, valuation, price trends and company information.
$311.06M | |
$6.08 | |
$6.08 | |
$5.97 | |
$6.04 | |
6.90K | |
1.14M | |
-- | |
$14.06 | |
$4.36 | |
-- | |
-- |
Emergent Biosolutions, Inc. (EBS) is currently trading at $6.03 as of 2026-11-12 14:35:00, down 0.66% ($0.04) from the previous close of $6.04
During today's regular trading session, EBS has traded between $5.97 and $6.08, with a trading volume of 6.90K shares. The current price is near the middle of today's range.
Over the past seven days, Emergent Biosolutions, Inc. (EBS) moved from $6.25 to $6.03, representing a decline of 3.50% ($0.22).
The stock traded between $5.51 and $7.22 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 1.43 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 17.2%
EBS is currently trading at $6.03, placing it 17.2% of the way from its 52-week low of $4.36 to its 52-week high of $14.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 900 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Emergent Biosolutions, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Emergent Biosolutions, Inc. (EBS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to EBS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between EBS shares and USD.
EBS Shares to USD
1.00 EBS shares = 6.031 USD
Calculations are estimates based on the latest available price and are for reference only.